International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 140436 - 140436
Published: Jan. 1, 2025
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 140436 - 140436
Published: Jan. 1, 2025
Language: Английский
Molecules, Journal Year: 2022, Volume and Issue: 27(13), P. 3994 - 3994
Published: June 21, 2022
For many decades, the thiazole moiety has been an important heterocycle in world of chemistry. The ring consists sulfur and nitrogen such a fashion that pi (π) electrons are free to move from one bond other bonds rendering aromatic properties. On account its aromaticity, reactive positions where donor–acceptor, nucleophilic, oxidation reactions, etc., may take place. Molecules containing ring, when entering physiological systems, behave unpredictably reset system differently. These molecules activate/stop biochemical pathways enzymes or stimulate/block receptors biological systems. Therefore, medicinal chemists have focusing their efforts on thiazole-bearing compounds order develop novel therapeutic agents for variety pathological conditions. This review attempts inform readers three major classes molecules: Thiazoles as treatment drugs, thiazoles clinical trials, preclinical developmental stages. A compilation is presented, brief synthetic description studies relating structure-based activity analysis. authors expect current succeed drawing attention finding new leads, which later be translated into drugs.
Language: Английский
Citations
114RSC Advances, Journal Year: 2022, Volume and Issue: 12(31), P. 19764 - 19855
Published: Jan. 1, 2022
The present review focuses on various heterocyclic scaffolds and their role in designing developing new potential AChE BChE inhibitors to treat AD.
Language: Английский
Citations
85Bioorganic & Medicinal Chemistry, Journal Year: 2022, Volume and Issue: 77, P. 117111 - 117111
Published: Nov. 29, 2022
Language: Английский
Citations
81Molecular Diversity, Journal Year: 2022, Volume and Issue: 26(5), P. 2825 - 2845
Published: April 9, 2022
Language: Английский
Citations
80Journal of Molecular Structure, Journal Year: 2022, Volume and Issue: 1257, P. 132613 - 132613
Published: Feb. 10, 2022
Language: Английский
Citations
74International Journal of Biological Macromolecules, Journal Year: 2023, Volume and Issue: 239, P. 124232 - 124232
Published: March 29, 2023
Language: Английский
Citations
68Bioorganic Chemistry, Journal Year: 2021, Volume and Issue: 113, P. 105009 - 105009
Published: May 23, 2021
Language: Английский
Citations
98Chemistry & Biodiversity, Journal Year: 2021, Volume and Issue: 18(4)
Published: Feb. 23, 2021
Abstract A series of six N ‐carbamimidoyl‐4‐(3‐substituted phenylureido)benzenesulfonamide derivatives were synthesized by reaction sulfaguanidine with aromatic isocyanates. In vitro and in silico inhibitory effects the novel ureido‐substituted investigated spectrophotometric methods for α‐glycosidase (α‐GLY), acetylcholinesterase (AChE), butyrylcholinesterase (BChE) enzymes associated diabetes mellitus (DM) Alzheimer's disease (AD). ‐Carbamimidoyl‐4‐{[(3,4‐dichlorophenyl)carbamoyl]amino}benzene‐1‐sulfonamide ( 2f ) showed AChE BChE effects, K I values 515.98±45.03 nM 598.47±59.18 nM, respectively, while ‐carbamimidoyl‐4‐{[(3‐chlorophenyl)carbamoyl]amino}benzene‐1‐sulfonamide 2e strong α‐GLY effect, 103.94±13.06 nM. The antidiabetic compounds are higher than their anti‐Alzheimer's because inhibition effect on diabetic enzyme is greater esterase enzymes. Indeed, metabolic important treatment DM AD.
Language: Английский
Citations
82Archiv der Pharmazie, Journal Year: 2020, Volume and Issue: 354(3)
Published: Nov. 6, 2020
Abstract Alzheimer's disease (AD) is a neurodegenerative disorder characterized by dementia, memory impairment, cognitive dysfunction, and speech impairment. The utility of cholinergic replacement acetylcholinesterase (AChE) inhibitors in AD treatment has been well documented so far. Recently, studies have also evidenced that human carbonic anhydrases (hCAs) serve as an important target for treatment. In this direction, the improvement new multitarget drugs, which can simultaneously modulate several mechanisms or targets included pathway, may be potent strategy to treat AD. light these data understanding developing AD‐related AChE hCAs inhibitors, study, novel methylene‐aminobenzoic acid tetrahydroisoquinolynyl‐benzoic derivatives ( 4a – g 6a ) were designed. synthesized analogs experimentally validated their effects vitro direct enzymatic tests. Also, compounds subjected silico monitoring with Schrödinger Suite software assign binding affinities potential based on Glide XP scoring, molecular mechanics‐generalized Born surface area computing, validation docking. results revealed 6c (1,3‐dimethyldihydropyrimidine‐2,4‐(1 H ,3 )‐dione‐substituted, K I value 33.00 ± 0.29 nM), 6e (cyclohexanone‐substituted, 18.78 0.09 6f (2,2‐dimethyl‐1,3‐dioxan‐4‐one‐substituted, 13.62 0.21 nM) from benzoic series most promising derivatives, they exhibited good multifunctional inhibition at all experimental levels against hCA I, II, AChE, respectively,
Language: Английский
Citations
81Journal of Biomolecular Structure and Dynamics, Journal Year: 2021, Volume and Issue: 40(22), P. 12008 - 12021
Published: Aug. 23, 2021
Aldose reductase (AR) and sorbitol dehydrogenase (SDH) are important enzymes of the polyol pathway. In current study, inhibitory effects vulpinic acid (VA) carnosic (CA) usnic (UA) on purified AR SDH were determined. These inhibition could be essential to prevent diabetic complications. from sheep kidney. Then, VA, CA UA tested in various concentrations against these activity vitro. KI values found as 1.46 ± 0.04, 5.13 0.25 11.71 0.27 μΜ for UA, respectively, AR. constants 15.32 0.34, 145.60 2.17 213.40 2.64 SDH. findings indicate that useful treatment complications.Communicated by Ramaswamy H. Sarma
Language: Английский
Citations
81